MENU
KLTO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Klotho Neurosciences (KLTO) Ownership - Who owns Klotho Neurosciences?
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.97M
P/E Ratio
N/A
Total Cash
50.9K
Projected Growth
N/A
Total Debt
151K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KLTO
Capitalization
4.97M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
50.9K
Total Cash/Share
0.00
Total Debt
151K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
1.46M
P/B Ratio
4.19
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
306K
Current Ratio
0.16
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
523K
Shares Outstanding - Current
28.5M
Total Liabilities
1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-64.041
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information